The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice

  1. Camille Dumon
  2. Diabe Diabira
  3. Ilona Chudotvorova
  4. Francesca Bader  Is a corresponding author
  5. Semra Sahin
  6. Jinwei Zhang
  7. Christophe Porcher
  8. Gary Wayman
  9. Igor Medina
  10. Jean-Luc Gaiarsa  Is a corresponding author
  1. Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), France
  2. Washington State University, United States
  3. University of Exeter Medical School, United Kingdom

Abstract

Brain computations rely on a proper balance between excitation and inhibition which progressively emerges during postnatal development in rodent. g-aminobutyric acid (GABA) neurotransmission supports inhibition in the adult brain but excites immature rodent neurons. Alterations in the timing of the GABA switch contribute to neurological disorders, so unveiling the involved regulators may be a promising strategy for treatment. Here we show that the adipocyte hormone leptin sets the tempo for the emergence of GABAergic inhibition in the newborn rodent hippocampus. In the absence of leptin signaling, hippocampal neurons show an advanced emergence of GABAergic inhibition. Conversely, maternal obesity associated with hyperleptinemia delays the excitatory to inhibitory switch of GABA action in offspring. This study uncovers a developmental function of leptin that may be linked to the pathogenesis of neurological disorders and helps understanding how maternal environment can adversely impact offspring brain development.

Data availability

All data generated or analyszed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 to 4 and Supplementary Figures 1 and 2.

Article and author information

Author details

  1. Camille Dumon

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Diabe Diabira

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Ilona Chudotvorova

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Francesca Bader

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    For correspondence
    francesca.bader@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  5. Semra Sahin

    Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jinwei Zhang

    Institute of Biochemical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8683-509X
  7. Christophe Porcher

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Gary Wayman

    Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Igor Medina

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6839-5414
  10. Jean-Luc Gaiarsa

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    For correspondence
    jean-luc.gaiarsa@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7354-0559

Funding

National Institutes of Health (Grant MH086032)

  • Gary Wayman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were carried out in accordance with the European Union Directive of 22 September (2010/63/EU).

Copyright

© 2018, Dumon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,783
    views
  • 252
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Camille Dumon
  2. Diabe Diabira
  3. Ilona Chudotvorova
  4. Francesca Bader
  5. Semra Sahin
  6. Jinwei Zhang
  7. Christophe Porcher
  8. Gary Wayman
  9. Igor Medina
  10. Jean-Luc Gaiarsa
(2018)
The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice
eLife 7:e36726.
https://doi.org/10.7554/eLife.36726

Share this article

https://doi.org/10.7554/eLife.36726

Further reading

    1. Medicine
    2. Neuroscience
    LeYuan Gu, WeiHui Shao ... HongHai Zhang
    Research Article

    The advent of midazolam holds profound implications for modern clinical practice. The hypnotic and sedative effects of midazolam afford it broad clinical applicability. However, the specific mechanisms underlying the modulation of altered consciousness by midazolam remain elusive. Herein, using pharmacology, optogenetics, chemogenetics, fiber photometry, and gene knockdown, this in vivo research revealed the role of locus coeruleus (LC)-ventrolateral preoptic nucleus noradrenergic neural circuit in regulating midazolam-induced altered consciousness. This effect was mediated by α1 adrenergic receptors. Moreover, gamma-aminobutyric acid receptor type A (GABAA-R) represents a mechanistically crucial binding site in the LC for midazolam. These findings will provide novel insights into the neural circuit mechanisms underlying the recovery of consciousness after midazolam administration and will help guide the timing of clinical dosing and propose effective intervention targets for timely recovery from midazolam-induced loss of consciousness.

    1. Neuroscience
    Ana Maria Ichim, Harald Barzan ... Raul Cristian Muresan
    Review Article

    Gamma oscillations in brain activity (30–150 Hz) have been studied for over 80 years. Although in the past three decades significant progress has been made to try to understand their functional role, a definitive answer regarding their causal implication in perception, cognition, and behavior still lies ahead of us. Here, we first review the basic neural mechanisms that give rise to gamma oscillations and then focus on two main pillars of exploration. The first pillar examines the major theories regarding their functional role in information processing in the brain, also highlighting critical viewpoints. The second pillar reviews a novel research direction that proposes a therapeutic role for gamma oscillations, namely the gamma entrainment using sensory stimulation (GENUS). We extensively discuss both the positive findings and the issues regarding reproducibility of GENUS. Going beyond the functional and therapeutic role of gamma, we propose a third pillar of exploration, where gamma, generated endogenously by cortical circuits, is essential for maintenance of healthy circuit function. We propose that four classes of interneurons, namely those expressing parvalbumin (PV), vasointestinal peptide (VIP), somatostatin (SST), and nitric oxide synthase (NOS) take advantage of endogenous gamma to perform active vasomotor control that maintains homeostasis in the neuronal tissue. According to this hypothesis, which we call GAMER (GAmma MEdiated ciRcuit maintenance), gamma oscillations act as a ‘servicing’ rhythm that enables efficient translation of neural activity into vascular responses that are essential for optimal neurometabolic processes. GAMER is an extension of GENUS, where endogenous rather than entrained gamma plays a fundamental role. Finally, we propose several critical experiments to test the GAMER hypothesis.